These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16242081)

  • 1. Hypersensitivity reactions to vaccine components.
    Heidary N; Cohen DE
    Dermatitis; 2005 Sep; 16(3):115-20. PubMed ID: 16242081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.
    Leventhal JS; Berger EM; Brauer JA; Cohen DE
    Dermatitis; 2012; 23(3):102-9. PubMed ID: 22653170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
    Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
    Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity and vaccines: an update.
    Barbaud A; Deschildre A; Waton J; Raison-Peyron N; Tréchot P
    Eur J Dermatol; 2013 Apr; 23(2):135-41. PubMed ID: 23238161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed allergic skin reactions to vaccines.
    Aquino MR; Bingemann TA; Nanda A; Maples KM
    Allergy Asthma Proc; 2022 Jan; 43(1):20-29. PubMed ID: 34983706
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on vaccine safety.
    Zimmerman RK; Kimmel SR; Trauth JM
    Am Fam Physician; 1996 Jul; 54(1):185-93. PubMed ID: 8677834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse reactions following anti-infective vaccinations.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Am J Clin Dermatol; 2005; 6(2):79-87. PubMed ID: 15799679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous reactions to vaccinations.
    Rosenblatt AE; Stein SL
    Clin Dermatol; 2015; 33(3):327-32. PubMed ID: 25889134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adverse events: separating myth from reality.
    Kimmel SR
    Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():689-96. PubMed ID: 22951450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.